Researchers at the University of California Los Angeles combined multimodal brain MRIs with clinical and personal data from 183 men and women to identify sex-specific brain signatures that could be indicative of what causes a person to develop obesity.

In some cases, certain classes of anti-amyloid beta (Aβ) drugs resulted in individuals’ brain volume decreasing more rapidly while using the drug than they would have if they had not received treatment at all. 

The radiologist's testimony is in regard to how the plaintiff, 76-year-old retired optometrist Terry Sanderson, sustained his injuries, which included broken ribs and head trauma resulting in a serious concussion.

In comparison to a cohort of individuals who were unaffected by either condition, the differences in brain stem volume were found to be significant, according to a paper published recently in Frontiers in Neuroscience. 

A recent analysis published in Multiple Sclerosis and Related Disorders found that these criteria often exclude children who display suspicious findings on imaging.

Redundant brain pathways can serve as pre-symptomatic indicators of mild cognitive impairment (MCI) in aging individuals, allowing care teams to design first-line neuropsychological exercises for slowing the possible approach of Alzheimer’s disease.

The risk stratification system was put to the test in more than 3,000 cases and proved itself to be a beneficial tool in predicting future AVM rupture across multiple risk groups.

When put to the test, the new model was able to predict Alzheimer’s risk with 90.2% accuracy.